SLC6A3 and Parkinson disease: The pathogenesis of PD involves dopaminergic neuronal markers that play crucial roles in dopamine synthesis and transport, including Tyrosine Hydroxylase (TH), Vesicular Monoamine Transporter 2 (VMAT2), and Dopamine Transporter (DAT) [52].